275 related articles for article (PubMed ID: 29538180)
1. Plaque brachytherapy for posterior uveal melanoma in 2018: improved techniques and expanded indications.
Reichstein D; Karan K
Curr Opin Ophthalmol; 2018 May; 29(3):191-198. PubMed ID: 29538180
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.
Badiyan SN; Rao RC; Apicelli AJ; Acharya S; Verma V; Garsa AA; DeWees T; Speirs CK; Garcia-Ramirez J; Esthappan J; Grigsby PW; Harbour JW
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):801-5. PubMed ID: 24462385
[TBL] [Abstract][Full Text] [Related]
3. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
[TBL] [Abstract][Full Text] [Related]
4. 23-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity.
McCannel TA; Kamrava M; Demanes J; Lamb J; Bartlett JD; Almanzor R; Chun M; McCannel CA
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2461-2467. PubMed ID: 27638702
[TBL] [Abstract][Full Text] [Related]
5. (106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence.
Barker CA; Francis JH; Cohen GN; Marr BP; Wolden SL; McCormick B; Abramson DH
Brachytherapy; 2014; 13(6):584-90. PubMed ID: 24880583
[TBL] [Abstract][Full Text] [Related]
6. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
7. Incidence and indications for pars plana vitrectomy following the treatment of posterior uveal melanomas in Scotland.
Chia SN; Smith HB; Hammer HM; Kemp EG
Eye (Lond); 2015 Jun; 29(6):748-56. PubMed ID: 25853443
[TBL] [Abstract][Full Text] [Related]
8. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
9. Postoperative Echography for Optimization of Radiation Dosimetry in Patients with Uveal Melanoma Treated with Plaque Brachytherapy.
Binkley EM; King BA; Hyer DE; Javed A; Milhem MM; Hinz CJ; Mott SL; Boldt HC
Ophthalmol Retina; 2023 Jul; 7(7):620-627. PubMed ID: 36822323
[TBL] [Abstract][Full Text] [Related]
10. Ocular complications after iodine brachytherapy for large uveal melanomas.
Puusaari I; Heikkonen J; Kivelä T
Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
[TBL] [Abstract][Full Text] [Related]
11. Palladium 103 plaque radiotherapy for uveal melanoma. Clinical experience.
Finger PT; Buffa A; Mishra S; Berson A; Bosworth JL; Vikram B
Ophthalmology; 1994 Feb; 101(2):256-63. PubMed ID: 8115147
[TBL] [Abstract][Full Text] [Related]
12. Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy.
Demirci H; Saponara F; Khan A; Niziol LM; Lee C; Hayman JA; Comer G; Musch DC
Middle East Afr J Ophthalmol; 2015; 22(1):103-7. PubMed ID: 25624683
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma.
Dean MK; Studenski MT; Paez-Escamilla MA; Walter SD; Kwon D; Markoe AM; Harbour JW; Samuels SE
Brachytherapy; 2019; 18(3):404-410. PubMed ID: 30797699
[TBL] [Abstract][Full Text] [Related]
14. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.
Quivey JM; Augsburger J; Snelling L; Brady LW
Cancer; 1996 Jun; 77(11):2356-62. PubMed ID: 8635107
[TBL] [Abstract][Full Text] [Related]
15. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma.
Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
Ophthalmology; 2010 May; 117(5):1005-12. PubMed ID: 20079924
[TBL] [Abstract][Full Text] [Related]
16. Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective review.
Vonk DT; Kim Y; Javid C; Gordon JD; Stea B
Brachytherapy; 2015; 14(5):726-33. PubMed ID: 26051804
[TBL] [Abstract][Full Text] [Related]
17. Vitreous hemorrhage after plaque radiotherapy for uveal melanoma.
Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
Retina; 2012 Jun; 32(6):1156-64. PubMed ID: 22366905
[TBL] [Abstract][Full Text] [Related]
18. Uveal melanomas. Conservation treatment.
Munzenrider JE
Hematol Oncol Clin North Am; 2001 Apr; 15(2):389-402. PubMed ID: 11370500
[TBL] [Abstract][Full Text] [Related]
19. Delivered dose changes in COMS plaque-based ocular brachytherapy arising from vitrectomy with silicone oil replacement.
Morrison H; Larocque MP; Menon G; Sloboda RS; Weis E
Brachytherapy; 2019; 18(5):668-674. PubMed ID: 31272841
[TBL] [Abstract][Full Text] [Related]
20. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
